- Report
- October 2025
- 109 Pages
Global
From €3132EUR$3,450USD£2,698GBP
- Report
- August 2025
- 115 Pages
Global
From €3132EUR$3,450USD£2,698GBP
- Report
- July 2025
- 200 Pages
United States
From €2260EUR$2,490USD£1,947GBP
- Report
- September 2025
- 200 Pages
North America
From €2260EUR$2,490USD£1,947GBP
- Report
- September 2025
- 90 Pages
Middle East
From €4493EUR$4,950USD£3,871GBP
- Report
- September 2025
- 85 Pages
United States
From €3177EUR$3,500USD£2,737GBP
- Report
- September 2025
- 85 Pages
United States
From €3177EUR$3,500USD£2,737GBP
- Report
- August 2025
- 130 Pages
Africa, Middle East
From €3631EUR$4,000USD£3,128GBP
- Report
- August 2025
- 130 Pages
Europe
From €3631EUR$4,000USD£3,128GBP
- Report
- July 2025
- 85 Pages
United States
From €3177EUR$3,500USD£2,737GBP
- Report
- March 2026
- 210 Pages
United States
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2026
- 278 Pages
United States
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2026
- 250 Pages
United States
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2026
- 310 Pages
United States
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2026
- 249 Pages
United States
From €4403EUR$4,850USD£3,793GBP
- Report
- February 2026
- 150 Pages
United States
From €4403EUR$4,850USD£3,793GBP
- Report
- October 2025
- 98 Pages
Middle East
From €4403EUR$4,850USD£3,793GBP
- Report
- October 2025
- 94 Pages
Middle East
From €4403EUR$4,850USD£3,793GBP
- Report
- October 2025
- 96 Pages
Asia Pacific
From €3586EUR$3,950USD£3,089GBP
- Report
- October 2025
- 100 Pages
Europe
From €3586EUR$3,950USD£3,089GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more